Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
Anhui Huaren Health Pharmaceutical Co., Ltd. operates in the medical and healthcare industry. It offers products for oral and throat, nourishing, heat-clearing, respiratory system, and gynecology, as well as provides vitamins and minerals, and detoxifying products. In addition, it provides supplements, and nutrition and health products. Anhui Huaren Health Pharmaceutical Co., Ltd. was founded in … Read more
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) - Total Assets
Latest total assets as of June 2025: CN¥5.26 Billion CNY
Based on the latest financial reports, Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) holds total assets worth CN¥5.26 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Total Assets Trend (2021–2024)
This chart illustrates how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Asset Composition Analysis
Current Asset Composition (December 2024)
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's total assets of CN¥5.26 Billion consist of 53.8% current assets and 46.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 20.7% |
| Accounts Receivable | CN¥454.17 Million | 9.4% |
| Inventory | CN¥863.84 Million | 17.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥69.94 Million | 1.5% |
| Goodwill | CN¥988.37 Million | 20.5% |
Asset Composition Trend (2021–2024)
This chart illustrates how Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's current assets represent 53.8% of total assets in 2024, a decrease from 56.5% in 2021.
- Cash Position: Cash and equivalents constituted 20.7% of total assets in 2024, up from 14.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, an increase from 9.0% in 2021.
- Asset Diversification: The largest asset category is goodwill at 20.5% of total assets.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Competitors by Total Assets
Key competitors of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Arich Enterprise Co Ltd
TWO:4173
|
Taiwan | NT$5.63 Billion |
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A generates 0.94x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A generates $ 2.85 in net profit.
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.06 | 1.26 | 1.26 |
| Quick Ratio | 0.65 | 0.82 | 0.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥135.28 Million | CN¥ 527.13 Million | CN¥ 527.13 Million |
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A - Advanced Valuation Insights
This section examines the relationship between Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.63 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 4.7% |
| Total Assets | CN¥4.83 Billion |
| Market Capitalization | $323.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's assets grew by 4.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2024)
The table below shows the annual total assets of Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.83 Billion | +4.69% |
| 2023-12-31 | CN¥4.61 Billion | +79.01% |
| 2022-12-31 | CN¥2.58 Billion | +30.70% |
| 2021-12-31 | CN¥1.97 Billion | -- |